Literature DB >> 8033548

Sodium lauryl sulphate penetration in an in vitro model using human skin.

A Fullerton1, U Broby-Johansen, T Agner.   

Abstract

Because of their ability to impair the skin barrier function, detergents constitute a major risk factor for the development of irritant contact dermatitis. Sodium lauryl sulphate (SLS) is a commonly used detergent for experimental studies within the area of irritant contact dermatitis. In the present study, penetration of S35-labelled SLS was studied in an in vitro model using human cadaver skin. The investigations showed that SLS is capable of permeating the skin barrier when applied under occlusion. SLS could be detected in the dermis and the amount of SLS found here was shown to depend on the dose of SLS applied on the skin. Penetration of SLS continued after removal of the SLS applied as a patch test on the skin surface. Considerable inter-individual variation in the penetration of SLS was demonstrated between different donors.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8033548     DOI: 10.1111/j.1600-0536.1994.tb00648.x

Source DB:  PubMed          Journal:  Contact Dermatitis        ISSN: 0105-1873            Impact factor:   6.600


  3 in total

1.  Urea-containing moisturizers influence barrier properties of normal skin.

Authors:  M Loden
Journal:  Arch Dermatol Res       Date:  1996-02       Impact factor: 3.017

2.  Imaging the distribution of sodium dodecyl sulfate in skin by confocal Raman and infrared microspectroscopy.

Authors:  G Mao; C R Flach; R Mendelsohn; R M Walters
Journal:  Pharm Res       Date:  2012-04-04       Impact factor: 4.200

3.  Winter season, frequent hand washing, and irritant patch test reactions to detergents are associated with hand dermatitis in health care workers.

Authors:  Adrienne Callahan; Elma Baron; Desta Fekedulegn; Michael Kashon; Berran Yucesoy; Victor J Johnson; Diana Santo Domingo; Brent Kirkland; Michael I Luster; Susan Nedorost
Journal:  Dermatitis       Date:  2013 Jul-Aug       Impact factor: 4.845

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.